Science Vs cover image

Introducing The Journal: Trillion Dollar Shot

Science Vs

00:00

Success of Victoza and Emerging Trends in ETFs

Liraglutide's success as Victoza for type 2 diabetes paved the way for a more successful weight loss drug, gaining popularity for its weight loss effects. The chapter also delves into Global X ETFs that track emerging trends like artificial intelligence, a reverse auctioneer service for mobile plan prices, and innovative practices at Novo Nordisk in Copenhagen.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app